title: New preclinical model are required to discover neuroprotective compound in Parkinson's disease.
authors.affiliation: Molecular & Clinical Pharmacology, ICBM, Faculty of Medicine, University of Chile, Santiago, Chile. Electronic address: jsegura@med.uchile.cl.
authors.forename: Juan
authors.initials: J
authors.lastname: Segura-Aguilar
mesh_terms: D000818:Animals; D004353:Drug Evaluation, Preclinical; D006801:Humans; D000066829:Neuroprotection / Q000187:drug effects*; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
chemical_list: D018696:Neuroprotective Agents